Bethesda, Maryland, USA, 14 November 2024 - A landmark paper by distinguished neuroendocrine psychiatrist Dr. Philip W. Gold, published in Brain Medicine's Seymour Reichlin Centenary Festschrift ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...

A GRASSINGTON woman conquered her fear of heights and took to the skies in a glider to raise money for a cancer charity close ...

A Fort Wright mom of four battling an extremely rare cancer is now helping in the fight for a cure. Five years ago, Kristy ...

The firm says that with paltusotine’s Phase 3 for carcinoid syndrome set to kick off before year-end, Crinetics unveils a new asset for neuroendocrine tumors. Crinetics again demonstrated its “drug ...

EXCLUSIVE: Jacqueline, 40, refuses to let her cancer diagnosis hold her back. In fact, she recently took on a saucy new role ...

In a report released yesterday, Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – ...

Jacqueline, 40, from Wakefield, West Yorkshire, was diagnosed with gastric neuroendocrine cancer, but she's still feeling ...

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...